nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoricoxib—Vismodegib—Sulfasalazine—ulcerative colitis	0.354	1	CrCrCtD
Etoricoxib—PTGS2—ulcerative colitis	0.153	1	CbGaD
Etoricoxib—PTGS2—Olsalazine—ulcerative colitis	0.0511	0.146	CbGbCtD
Etoricoxib—PTGS2—Balsalazide—ulcerative colitis	0.0456	0.13	CbGbCtD
Etoricoxib—PTGS2—Mesalazine—ulcerative colitis	0.0364	0.104	CbGbCtD
Etoricoxib—PTGS2—Sulfasalazine—ulcerative colitis	0.0203	0.0579	CbGbCtD
Etoricoxib—PTGS2—Triamcinolone—ulcerative colitis	0.0203	0.0579	CbGbCtD
Etoricoxib—PTGS2—Betamethasone—ulcerative colitis	0.0175	0.0497	CbGbCtD
Etoricoxib—CYP2E1—Nicotine—ulcerative colitis	0.0171	0.0486	CbGbCtD
Etoricoxib—CYP3A4—Budesonide—ulcerative colitis	0.0119	0.0338	CbGbCtD
Etoricoxib—CYP2C19—Nicotine—ulcerative colitis	0.0107	0.0305	CbGbCtD
Etoricoxib—PTGS2—Dexamethasone—ulcerative colitis	0.0102	0.0289	CbGbCtD
Etoricoxib—CYP1A2—Nicotine—ulcerative colitis	0.00987	0.0281	CbGbCtD
Etoricoxib—CYP2C19—Cholecalciferol—ulcerative colitis	0.00959	0.0273	CbGbCtD
Etoricoxib—CYP2C9—Nicotine—ulcerative colitis	0.00889	0.0253	CbGbCtD
Etoricoxib—CYP2D6—Nicotine—ulcerative colitis	0.00813	0.0232	CbGbCtD
Etoricoxib—CYP2C9—Cholecalciferol—ulcerative colitis	0.00798	0.0227	CbGbCtD
Etoricoxib—CYP2D6—Cholecalciferol—ulcerative colitis	0.00729	0.0208	CbGbCtD
Etoricoxib—CYP2C19—Prednisone—ulcerative colitis	0.00665	0.0189	CbGbCtD
Etoricoxib—CYP2E1—Dexamethasone—ulcerative colitis	0.00662	0.0189	CbGbCtD
Etoricoxib—CYP3A4—Methylprednisolone—ulcerative colitis	0.00531	0.0151	CbGbCtD
Etoricoxib—CYP3A4—Nicotine—ulcerative colitis	0.00517	0.0147	CbGbCtD
Etoricoxib—CYP3A4—Cholecalciferol—ulcerative colitis	0.00464	0.0132	CbGbCtD
Etoricoxib—CYP2C19—Dexamethasone—ulcerative colitis	0.00415	0.0118	CbGbCtD
Etoricoxib—CYP3A4—Triamcinolone—ulcerative colitis	0.00402	0.0114	CbGbCtD
Etoricoxib—CYP2C9—Dexamethasone—ulcerative colitis	0.00345	0.00983	CbGbCtD
Etoricoxib—CYP3A4—Betamethasone—ulcerative colitis	0.00345	0.00982	CbGbCtD
Etoricoxib—CYP3A4—Prednisolone—ulcerative colitis	0.0034	0.00969	CbGbCtD
Etoricoxib—CYP3A4—Hydrocortisone—ulcerative colitis	0.00323	0.00919	CbGbCtD
Etoricoxib—CYP3A4—Prednisone—ulcerative colitis	0.00321	0.00915	CbGbCtD
Etoricoxib—CYP2D6—Dexamethasone—ulcerative colitis	0.00316	0.00899	CbGbCtD
Etoricoxib—CYP3A4—Dexamethasone—ulcerative colitis	0.00201	0.00571	CbGbCtD
Etoricoxib—Vemurafenib—ALB—ulcerative colitis	0.000596	0.309	CrCbGaD
Etoricoxib—PTGS2—Fluocinonide—Budesonide—ulcerative colitis	0.000475	0.247	CbGdCrCtD
Etoricoxib—Celecoxib—PTGS2—ulcerative colitis	0.000393	0.204	CrCbGaD
Etoricoxib—Celecoxib—ALB—ulcerative colitis	0.00035	0.182	CrCbGaD
Etoricoxib—Vismodegib—ALB—ulcerative colitis	0.0003	0.156	CrCbGaD
Etoricoxib—Vismodegib—ABCB1—ulcerative colitis	0.000287	0.149	CrCbGaD
Etoricoxib—PTGS2—Fluocinonide—Methylprednisolone—ulcerative colitis	0.00023	0.119	CbGdCrCtD
Etoricoxib—PTGS2—Fluocinonide—Betamethasone—ulcerative colitis	0.000226	0.118	CbGdCrCtD
Etoricoxib—PTGS2—Fluocinonide—Dexamethasone—ulcerative colitis	0.000226	0.118	CbGdCrCtD
Etoricoxib—PTGS2—Fluocinonide—Triamcinolone—ulcerative colitis	0.000221	0.115	CbGdCrCtD
Etoricoxib—MAPK14—epithelium—ulcerative colitis	0.000166	0.125	CbGeAlD
Etoricoxib—MAPK14—smooth muscle tissue—ulcerative colitis	0.00016	0.12	CbGeAlD
Etoricoxib—PTGS2—Fluticasone Propionate—Methylprednisolone—ulcerative colitis	0.000139	0.0721	CbGdCrCtD
Etoricoxib—PTGS2—Fluticasone Propionate—Betamethasone—ulcerative colitis	0.000136	0.071	CbGdCrCtD
Etoricoxib—PTGS2—Fluticasone Propionate—Dexamethasone—ulcerative colitis	0.000136	0.071	CbGdCrCtD
Etoricoxib—PTGS2—Fluticasone Propionate—Triamcinolone—ulcerative colitis	0.000133	0.0693	CbGdCrCtD
Etoricoxib—MAPK14—lymphoid tissue—ulcerative colitis	0.000128	0.0962	CbGeAlD
Etoricoxib—MAPK14—digestive system—ulcerative colitis	0.000127	0.095	CbGeAlD
Etoricoxib—MAPK14—liver—ulcerative colitis	9.42e-05	0.0708	CbGeAlD
Etoricoxib—Acute coronary syndrome—Prednisone—ulcerative colitis	5.84e-05	0.000656	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Mesalazine—ulcerative colitis	5.84e-05	0.000656	CcSEcCtD
Etoricoxib—Angioedema—Prednisolone—ulcerative colitis	5.83e-05	0.000654	CcSEcCtD
Etoricoxib—Neuropathy peripheral—Prednisone—ulcerative colitis	5.81e-05	0.000653	CcSEcCtD
Etoricoxib—Myocardial infarction—Prednisone—ulcerative colitis	5.81e-05	0.000653	CcSEcCtD
Etoricoxib—Dizziness—Budesonide—ulcerative colitis	5.81e-05	0.000653	CcSEcCtD
Etoricoxib—Hypersensitivity—Azathioprine—ulcerative colitis	5.78e-05	0.000649	CcSEcCtD
Etoricoxib—Dysgeusia—Triamcinolone—ulcerative colitis	5.74e-05	0.000645	CcSEcCtD
Etoricoxib—Eye disorder—Betamethasone—ulcerative colitis	5.71e-05	0.000641	CcSEcCtD
Etoricoxib—Eye disorder—Dexamethasone—ulcerative colitis	5.71e-05	0.000641	CcSEcCtD
Etoricoxib—Angioedema—Hydrocortisone—ulcerative colitis	5.69e-05	0.000639	CcSEcCtD
Etoricoxib—Urticaria—Mesalazine—ulcerative colitis	5.68e-05	0.000638	CcSEcCtD
Etoricoxib—Abdominal pain—Mesalazine—ulcerative colitis	5.65e-05	0.000634	CcSEcCtD
Etoricoxib—Vomiting—Budesonide—ulcerative colitis	5.59e-05	0.000627	CcSEcCtD
Etoricoxib—Angiopathy—Dexamethasone—ulcerative colitis	5.54e-05	0.000623	CcSEcCtD
Etoricoxib—Angiopathy—Betamethasone—ulcerative colitis	5.54e-05	0.000623	CcSEcCtD
Etoricoxib—Rash—Budesonide—ulcerative colitis	5.54e-05	0.000622	CcSEcCtD
Etoricoxib—Dermatitis—Budesonide—ulcerative colitis	5.54e-05	0.000622	CcSEcCtD
Etoricoxib—Headache—Budesonide—ulcerative colitis	5.51e-05	0.000618	CcSEcCtD
Etoricoxib—Hypertension—Prednisolone—ulcerative colitis	5.5e-05	0.000618	CcSEcCtD
Etoricoxib—Arrhythmia—Dexamethasone—ulcerative colitis	5.46e-05	0.000613	CcSEcCtD
Etoricoxib—Arrhythmia—Betamethasone—ulcerative colitis	5.46e-05	0.000613	CcSEcCtD
Etoricoxib—Alopecia—Betamethasone—ulcerative colitis	5.4e-05	0.000606	CcSEcCtD
Etoricoxib—Alopecia—Dexamethasone—ulcerative colitis	5.4e-05	0.000606	CcSEcCtD
Etoricoxib—CYP2C19—digestive system—ulcerative colitis	5.38e-05	0.0404	CbGeAlD
Etoricoxib—Hypertension—Hydrocortisone—ulcerative colitis	5.38e-05	0.000604	CcSEcCtD
Etoricoxib—Diarrhoea—Azathioprine—ulcerative colitis	5.37e-05	0.000603	CcSEcCtD
Etoricoxib—Angioedema—Triamcinolone—ulcerative colitis	5.36e-05	0.000602	CcSEcCtD
Etoricoxib—Haemoglobin—Prednisone—ulcerative colitis	5.35e-05	0.000601	CcSEcCtD
Etoricoxib—Angioedema—Methylprednisolone—ulcerative colitis	5.35e-05	0.0006	CcSEcCtD
Etoricoxib—Haemorrhage—Prednisone—ulcerative colitis	5.32e-05	0.000598	CcSEcCtD
Etoricoxib—Erythema—Dexamethasone—ulcerative colitis	5.32e-05	0.000597	CcSEcCtD
Etoricoxib—Erythema—Betamethasone—ulcerative colitis	5.32e-05	0.000597	CcSEcCtD
Etoricoxib—Hallucination—Prednisone—ulcerative colitis	5.3e-05	0.000595	CcSEcCtD
Etoricoxib—Anxiety—Hydrocortisone—ulcerative colitis	5.28e-05	0.000593	CcSEcCtD
Etoricoxib—Hypersensitivity—Mesalazine—ulcerative colitis	5.27e-05	0.000591	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	5.26e-05	0.000591	CcSEcCtD
Etoricoxib—Connective tissue disorder—Prednisone—ulcerative colitis	5.23e-05	0.000587	CcSEcCtD
Etoricoxib—Nausea—Budesonide—ulcerative colitis	5.22e-05	0.000586	CcSEcCtD
Etoricoxib—Anaphylactic shock—Prednisolone—ulcerative colitis	5.2e-05	0.000584	CcSEcCtD
Etoricoxib—Oedema—Prednisolone—ulcerative colitis	5.2e-05	0.000584	CcSEcCtD
Etoricoxib—Dizziness—Azathioprine—ulcerative colitis	5.19e-05	0.000583	CcSEcCtD
Etoricoxib—Asthenia—Mesalazine—ulcerative colitis	5.13e-05	0.000576	CcSEcCtD
Etoricoxib—Shock—Prednisolone—ulcerative colitis	5.12e-05	0.000575	CcSEcCtD
Etoricoxib—Cough—Triamcinolone—ulcerative colitis	5.12e-05	0.000575	CcSEcCtD
Etoricoxib—Oedema—Hydrocortisone—ulcerative colitis	5.08e-05	0.000571	CcSEcCtD
Etoricoxib—Anaphylactic shock—Hydrocortisone—ulcerative colitis	5.08e-05	0.000571	CcSEcCtD
Etoricoxib—Hypertension—Triamcinolone—ulcerative colitis	5.06e-05	0.000568	CcSEcCtD
Etoricoxib—Pruritus—Mesalazine—ulcerative colitis	5.06e-05	0.000568	CcSEcCtD
Etoricoxib—Hypertension—Methylprednisolone—ulcerative colitis	5.05e-05	0.000567	CcSEcCtD
Etoricoxib—Infection—Hydrocortisone—ulcerative colitis	5.05e-05	0.000567	CcSEcCtD
Etoricoxib—Shock—Hydrocortisone—ulcerative colitis	5e-05	0.000561	CcSEcCtD
Etoricoxib—Vomiting—Azathioprine—ulcerative colitis	4.99e-05	0.00056	CcSEcCtD
Etoricoxib—Nervous system disorder—Hydrocortisone—ulcerative colitis	4.98e-05	0.00056	CcSEcCtD
Etoricoxib—Arthralgia—Methylprednisolone—ulcerative colitis	4.98e-05	0.000559	CcSEcCtD
Etoricoxib—Eye disorder—Prednisone—ulcerative colitis	4.97e-05	0.000559	CcSEcCtD
Etoricoxib—Anxiety—Methylprednisolone—ulcerative colitis	4.96e-05	0.000557	CcSEcCtD
Etoricoxib—Rash—Azathioprine—ulcerative colitis	4.95e-05	0.000556	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	4.95e-05	0.000555	CcSEcCtD
Etoricoxib—Dermatitis—Azathioprine—ulcerative colitis	4.94e-05	0.000555	CcSEcCtD
Etoricoxib—Flushing—Prednisone—ulcerative colitis	4.94e-05	0.000555	CcSEcCtD
Etoricoxib—Skin disorder—Hydrocortisone—ulcerative colitis	4.94e-05	0.000554	CcSEcCtD
Etoricoxib—Headache—Azathioprine—ulcerative colitis	4.92e-05	0.000552	CcSEcCtD
Etoricoxib—Diarrhoea—Mesalazine—ulcerative colitis	4.89e-05	0.000549	CcSEcCtD
Etoricoxib—Dry mouth—Triamcinolone—ulcerative colitis	4.88e-05	0.000548	CcSEcCtD
Etoricoxib—Angioedema—Betamethasone—ulcerative colitis	4.86e-05	0.000546	CcSEcCtD
Etoricoxib—Angioedema—Dexamethasone—ulcerative colitis	4.86e-05	0.000546	CcSEcCtD
Etoricoxib—Anorexia—Hydrocortisone—ulcerative colitis	4.84e-05	0.000544	CcSEcCtD
Etoricoxib—Angiopathy—Prednisone—ulcerative colitis	4.83e-05	0.000542	CcSEcCtD
Etoricoxib—Confusional state—Methylprednisolone—ulcerative colitis	4.81e-05	0.000541	CcSEcCtD
Etoricoxib—Immune system disorder—Prednisone—ulcerative colitis	4.81e-05	0.00054	CcSEcCtD
Etoricoxib—Anaphylactic shock—Triamcinolone—ulcerative colitis	4.79e-05	0.000537	CcSEcCtD
Etoricoxib—Oedema—Triamcinolone—ulcerative colitis	4.79e-05	0.000537	CcSEcCtD
Etoricoxib—PTGS2—epithelium—ulcerative colitis	4.78e-05	0.0359	CbGeAlD
Etoricoxib—Anaphylactic shock—Methylprednisolone—ulcerative colitis	4.77e-05	0.000536	CcSEcCtD
Etoricoxib—Arrhythmia—Prednisone—ulcerative colitis	4.75e-05	0.000534	CcSEcCtD
Etoricoxib—Infection—Triamcinolone—ulcerative colitis	4.75e-05	0.000534	CcSEcCtD
Etoricoxib—Infection—Methylprednisolone—ulcerative colitis	4.74e-05	0.000533	CcSEcCtD
Etoricoxib—Dizziness—Mesalazine—ulcerative colitis	4.73e-05	0.000531	CcSEcCtD
Etoricoxib—Shock—Triamcinolone—ulcerative colitis	4.71e-05	0.000529	CcSEcCtD
Etoricoxib—Insomnia—Prednisolone—ulcerative colitis	4.71e-05	0.000528	CcSEcCtD
Etoricoxib—Alopecia—Prednisone—ulcerative colitis	4.7e-05	0.000528	CcSEcCtD
Etoricoxib—Shock—Methylprednisolone—ulcerative colitis	4.7e-05	0.000527	CcSEcCtD
Etoricoxib—Nervous system disorder—Methylprednisolone—ulcerative colitis	4.68e-05	0.000526	CcSEcCtD
Etoricoxib—Mental disorder—Prednisone—ulcerative colitis	4.66e-05	0.000524	CcSEcCtD
Etoricoxib—Nausea—Azathioprine—ulcerative colitis	4.66e-05	0.000523	CcSEcCtD
Etoricoxib—Skin disorder—Methylprednisolone—ulcerative colitis	4.64e-05	0.000521	CcSEcCtD
Etoricoxib—Erythema—Prednisone—ulcerative colitis	4.63e-05	0.00052	CcSEcCtD
Etoricoxib—Malnutrition—Prednisone—ulcerative colitis	4.63e-05	0.00052	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	4.63e-05	0.00052	CcSEcCtD
Etoricoxib—PTGS2—smooth muscle tissue—ulcerative colitis	4.61e-05	0.0346	CbGeAlD
Etoricoxib—Insomnia—Hydrocortisone—ulcerative colitis	4.6e-05	0.000516	CcSEcCtD
Etoricoxib—Hypertension—Dexamethasone—ulcerative colitis	4.59e-05	0.000516	CcSEcCtD
Etoricoxib—Hypertension—Betamethasone—ulcerative colitis	4.59e-05	0.000516	CcSEcCtD
Etoricoxib—Vomiting—Mesalazine—ulcerative colitis	4.54e-05	0.00051	CcSEcCtD
Etoricoxib—Anxiety—Dexamethasone—ulcerative colitis	4.51e-05	0.000507	CcSEcCtD
Etoricoxib—Anxiety—Betamethasone—ulcerative colitis	4.51e-05	0.000507	CcSEcCtD
Etoricoxib—Rash—Mesalazine—ulcerative colitis	4.51e-05	0.000506	CcSEcCtD
Etoricoxib—Dermatitis—Mesalazine—ulcerative colitis	4.5e-05	0.000506	CcSEcCtD
Etoricoxib—Headache—Mesalazine—ulcerative colitis	4.48e-05	0.000503	CcSEcCtD
Etoricoxib—Dyspepsia—Hydrocortisone—ulcerative colitis	4.47e-05	0.000502	CcSEcCtD
Etoricoxib—Pain—Prednisolone—ulcerative colitis	4.45e-05	0.0005	CcSEcCtD
Etoricoxib—Decreased appetite—Hydrocortisone—ulcerative colitis	4.42e-05	0.000496	CcSEcCtD
Etoricoxib—CYP1A2—digestive system—ulcerative colitis	4.39e-05	0.033	CbGeAlD
Etoricoxib—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	4.39e-05	0.000493	CcSEcCtD
Etoricoxib—Fatigue—Hydrocortisone—ulcerative colitis	4.38e-05	0.000492	CcSEcCtD
Etoricoxib—Vision blurred—Prednisone—ulcerative colitis	4.37e-05	0.00049	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	4.36e-05	0.00049	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	4.35e-05	0.000488	CcSEcCtD
Etoricoxib—Pain—Hydrocortisone—ulcerative colitis	4.35e-05	0.000488	CcSEcCtD
Etoricoxib—Anaphylactic shock—Betamethasone—ulcerative colitis	4.34e-05	0.000488	CcSEcCtD
Etoricoxib—Anaphylactic shock—Dexamethasone—ulcerative colitis	4.34e-05	0.000488	CcSEcCtD
Etoricoxib—Oedema—Dexamethasone—ulcerative colitis	4.34e-05	0.000488	CcSEcCtD
Etoricoxib—Oedema—Betamethasone—ulcerative colitis	4.34e-05	0.000488	CcSEcCtD
Etoricoxib—Insomnia—Triamcinolone—ulcerative colitis	4.33e-05	0.000486	CcSEcCtD
Etoricoxib—Insomnia—Methylprednisolone—ulcerative colitis	4.32e-05	0.000485	CcSEcCtD
Etoricoxib—Infection—Betamethasone—ulcerative colitis	4.31e-05	0.000484	CcSEcCtD
Etoricoxib—Infection—Dexamethasone—ulcerative colitis	4.31e-05	0.000484	CcSEcCtD
Etoricoxib—Feeling abnormal—Prednisolone—ulcerative colitis	4.29e-05	0.000482	CcSEcCtD
Etoricoxib—Anaemia—Prednisone—ulcerative colitis	4.28e-05	0.000481	CcSEcCtD
Etoricoxib—Shock—Dexamethasone—ulcerative colitis	4.27e-05	0.00048	CcSEcCtD
Etoricoxib—Shock—Betamethasone—ulcerative colitis	4.27e-05	0.00048	CcSEcCtD
Etoricoxib—Dyspnoea—Triamcinolone—ulcerative colitis	4.27e-05	0.000479	CcSEcCtD
Etoricoxib—Nervous system disorder—Dexamethasone—ulcerative colitis	4.26e-05	0.000478	CcSEcCtD
Etoricoxib—Nervous system disorder—Betamethasone—ulcerative colitis	4.26e-05	0.000478	CcSEcCtD
Etoricoxib—Agitation—Prednisone—ulcerative colitis	4.26e-05	0.000478	CcSEcCtD
Etoricoxib—Thrombocytopenia—Betamethasone—ulcerative colitis	4.25e-05	0.000477	CcSEcCtD
Etoricoxib—Thrombocytopenia—Dexamethasone—ulcerative colitis	4.25e-05	0.000477	CcSEcCtD
Etoricoxib—Nausea—Mesalazine—ulcerative colitis	4.25e-05	0.000477	CcSEcCtD
Etoricoxib—Angioedema—Prednisone—ulcerative colitis	4.23e-05	0.000475	CcSEcCtD
Etoricoxib—Dyspepsia—Triamcinolone—ulcerative colitis	4.21e-05	0.000473	CcSEcCtD
Etoricoxib—Dyspepsia—Methylprednisolone—ulcerative colitis	4.2e-05	0.000472	CcSEcCtD
Etoricoxib—Feeling abnormal—Hydrocortisone—ulcerative colitis	4.19e-05	0.00047	CcSEcCtD
Etoricoxib—CYP2C9—digestive system—ulcerative colitis	4.17e-05	0.0313	CbGeAlD
Etoricoxib—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	4.16e-05	0.000467	CcSEcCtD
Etoricoxib—Anorexia—Betamethasone—ulcerative colitis	4.14e-05	0.000465	CcSEcCtD
Etoricoxib—Anorexia—Dexamethasone—ulcerative colitis	4.14e-05	0.000465	CcSEcCtD
Etoricoxib—Urticaria—Prednisolone—ulcerative colitis	4.13e-05	0.000464	CcSEcCtD
Etoricoxib—Fatigue—Triamcinolone—ulcerative colitis	4.13e-05	0.000463	CcSEcCtD
Etoricoxib—Fatigue—Methylprednisolone—ulcerative colitis	4.12e-05	0.000462	CcSEcCtD
Etoricoxib—Pain—Triamcinolone—ulcerative colitis	4.09e-05	0.00046	CcSEcCtD
Etoricoxib—Urticaria—Hydrocortisone—ulcerative colitis	4.04e-05	0.000453	CcSEcCtD
Etoricoxib—Abdominal pain—Hydrocortisone—ulcerative colitis	4.02e-05	0.000451	CcSEcCtD
Etoricoxib—CYP2C19—liver—ulcerative colitis	4.01e-05	0.0301	CbGeAlD
Etoricoxib—Hypertension—Prednisone—ulcerative colitis	4e-05	0.000449	CcSEcCtD
Etoricoxib—CYP2E1—lymphoid tissue—ulcerative colitis	4e-05	0.03	CbGeAlD
Etoricoxib—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	3.96e-05	0.000444	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	3.96e-05	0.000444	CcSEcCtD
Etoricoxib—CYP2E1—digestive system—ulcerative colitis	3.95e-05	0.0297	CbGeAlD
Etoricoxib—Arthralgia—Prednisone—ulcerative colitis	3.94e-05	0.000443	CcSEcCtD
Etoricoxib—Feeling abnormal—Triamcinolone—ulcerative colitis	3.94e-05	0.000443	CcSEcCtD
Etoricoxib—Feeling abnormal—Methylprednisolone—ulcerative colitis	3.93e-05	0.000442	CcSEcCtD
Etoricoxib—Anxiety—Prednisone—ulcerative colitis	3.93e-05	0.000441	CcSEcCtD
Etoricoxib—Insomnia—Dexamethasone—ulcerative colitis	3.93e-05	0.000441	CcSEcCtD
Etoricoxib—Insomnia—Betamethasone—ulcerative colitis	3.93e-05	0.000441	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	3.92e-05	0.00044	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	3.9e-05	0.000438	CcSEcCtD
Etoricoxib—Hypersensitivity—Prednisolone—ulcerative colitis	3.83e-05	0.00043	CcSEcCtD
Etoricoxib—Dyspepsia—Betamethasone—ulcerative colitis	3.82e-05	0.000429	CcSEcCtD
Etoricoxib—Dyspepsia—Dexamethasone—ulcerative colitis	3.82e-05	0.000429	CcSEcCtD
Etoricoxib—Urticaria—Triamcinolone—ulcerative colitis	3.8e-05	0.000427	CcSEcCtD
Etoricoxib—Urticaria—Methylprednisolone—ulcerative colitis	3.79e-05	0.000426	CcSEcCtD
Etoricoxib—Anaphylactic shock—Prednisone—ulcerative colitis	3.78e-05	0.000425	CcSEcCtD
Etoricoxib—Oedema—Prednisone—ulcerative colitis	3.78e-05	0.000425	CcSEcCtD
Etoricoxib—Abdominal pain—Methylprednisolone—ulcerative colitis	3.77e-05	0.000424	CcSEcCtD
Etoricoxib—Decreased appetite—Betamethasone—ulcerative colitis	3.77e-05	0.000424	CcSEcCtD
Etoricoxib—Decreased appetite—Dexamethasone—ulcerative colitis	3.77e-05	0.000424	CcSEcCtD
Etoricoxib—Infection—Prednisone—ulcerative colitis	3.76e-05	0.000422	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	3.75e-05	0.000421	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Betamethasone—ulcerative colitis	3.75e-05	0.000421	CcSEcCtD
Etoricoxib—Hypersensitivity—Hydrocortisone—ulcerative colitis	3.74e-05	0.00042	CcSEcCtD
Etoricoxib—Fatigue—Betamethasone—ulcerative colitis	3.74e-05	0.00042	CcSEcCtD
Etoricoxib—Fatigue—Dexamethasone—ulcerative colitis	3.74e-05	0.00042	CcSEcCtD
Etoricoxib—Shock—Prednisone—ulcerative colitis	3.72e-05	0.000418	CcSEcCtD
Etoricoxib—Pain—Betamethasone—ulcerative colitis	3.71e-05	0.000417	CcSEcCtD
Etoricoxib—Pain—Dexamethasone—ulcerative colitis	3.71e-05	0.000417	CcSEcCtD
Etoricoxib—Nervous system disorder—Prednisone—ulcerative colitis	3.71e-05	0.000416	CcSEcCtD
Etoricoxib—PTGS2—lymphoid tissue—ulcerative colitis	3.68e-05	0.0277	CbGeAlD
Etoricoxib—Skin disorder—Prednisone—ulcerative colitis	3.67e-05	0.000412	CcSEcCtD
Etoricoxib—Asthenia—Hydrocortisone—ulcerative colitis	3.65e-05	0.000409	CcSEcCtD
Etoricoxib—PTGS2—digestive system—ulcerative colitis	3.64e-05	0.0273	CbGeAlD
Etoricoxib—Anorexia—Prednisone—ulcerative colitis	3.6e-05	0.000405	CcSEcCtD
Etoricoxib—Pruritus—Hydrocortisone—ulcerative colitis	3.6e-05	0.000404	CcSEcCtD
Etoricoxib—Feeling abnormal—Betamethasone—ulcerative colitis	3.58e-05	0.000402	CcSEcCtD
Etoricoxib—Feeling abnormal—Dexamethasone—ulcerative colitis	3.58e-05	0.000402	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Betamethasone—ulcerative colitis	3.55e-05	0.000399	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Dexamethasone—ulcerative colitis	3.55e-05	0.000399	CcSEcCtD
Etoricoxib—Hypersensitivity—Triamcinolone—ulcerative colitis	3.53e-05	0.000396	CcSEcCtD
Etoricoxib—Hypersensitivity—Methylprednisolone—ulcerative colitis	3.52e-05	0.000395	CcSEcCtD
Etoricoxib—Diarrhoea—Hydrocortisone—ulcerative colitis	3.48e-05	0.00039	CcSEcCtD
Etoricoxib—Urticaria—Betamethasone—ulcerative colitis	3.45e-05	0.000387	CcSEcCtD
Etoricoxib—Urticaria—Dexamethasone—ulcerative colitis	3.45e-05	0.000387	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Prednisone—ulcerative colitis	3.45e-05	0.000387	CcSEcCtD
Etoricoxib—Dizziness—Prednisolone—ulcerative colitis	3.44e-05	0.000386	CcSEcCtD
Etoricoxib—Asthenia—Triamcinolone—ulcerative colitis	3.43e-05	0.000386	CcSEcCtD
Etoricoxib—Abdominal pain—Dexamethasone—ulcerative colitis	3.43e-05	0.000385	CcSEcCtD
Etoricoxib—Abdominal pain—Betamethasone—ulcerative colitis	3.43e-05	0.000385	CcSEcCtD
Etoricoxib—Asthenia—Methylprednisolone—ulcerative colitis	3.43e-05	0.000385	CcSEcCtD
Etoricoxib—Insomnia—Prednisone—ulcerative colitis	3.42e-05	0.000384	CcSEcCtD
Etoricoxib—Pruritus—Triamcinolone—ulcerative colitis	3.39e-05	0.00038	CcSEcCtD
Etoricoxib—Pruritus—Methylprednisolone—ulcerative colitis	3.38e-05	0.000379	CcSEcCtD
Etoricoxib—Dizziness—Hydrocortisone—ulcerative colitis	3.36e-05	0.000377	CcSEcCtD
Etoricoxib—Dyspepsia—Prednisone—ulcerative colitis	3.33e-05	0.000374	CcSEcCtD
Etoricoxib—Decreased appetite—Prednisone—ulcerative colitis	3.29e-05	0.000369	CcSEcCtD
Etoricoxib—Rash—Prednisolone—ulcerative colitis	3.28e-05	0.000368	CcSEcCtD
Etoricoxib—Dermatitis—Prednisolone—ulcerative colitis	3.28e-05	0.000368	CcSEcCtD
Etoricoxib—CYP1A2—liver—ulcerative colitis	3.27e-05	0.0246	CbGeAlD
Etoricoxib—Diarrhoea—Methylprednisolone—ulcerative colitis	3.27e-05	0.000367	CcSEcCtD
Etoricoxib—Fatigue—Prednisone—ulcerative colitis	3.26e-05	0.000366	CcSEcCtD
Etoricoxib—Headache—Prednisolone—ulcerative colitis	3.26e-05	0.000366	CcSEcCtD
Etoricoxib—Constipation—Prednisone—ulcerative colitis	3.23e-05	0.000363	CcSEcCtD
Etoricoxib—Vomiting—Hydrocortisone—ulcerative colitis	3.23e-05	0.000363	CcSEcCtD
Etoricoxib—Rash—Hydrocortisone—ulcerative colitis	3.2e-05	0.00036	CcSEcCtD
Etoricoxib—Dermatitis—Hydrocortisone—ulcerative colitis	3.2e-05	0.000359	CcSEcCtD
Etoricoxib—Headache—Hydrocortisone—ulcerative colitis	3.18e-05	0.000358	CcSEcCtD
Etoricoxib—CYP3A4—digestive system—ulcerative colitis	3.18e-05	0.0239	CbGeAlD
Etoricoxib—Dizziness—Triamcinolone—ulcerative colitis	3.16e-05	0.000355	CcSEcCtD
Etoricoxib—Dizziness—Methylprednisolone—ulcerative colitis	3.16e-05	0.000355	CcSEcCtD
Etoricoxib—CYP2D6—digestive system—ulcerative colitis	3.13e-05	0.0235	CbGeAlD
Etoricoxib—Feeling abnormal—Prednisone—ulcerative colitis	3.12e-05	0.00035	CcSEcCtD
Etoricoxib—Asthenia—Betamethasone—ulcerative colitis	3.12e-05	0.00035	CcSEcCtD
Etoricoxib—Asthenia—Dexamethasone—ulcerative colitis	3.12e-05	0.00035	CcSEcCtD
Etoricoxib—CYP2C9—liver—ulcerative colitis	3.11e-05	0.0233	CbGeAlD
Etoricoxib—Gastrointestinal pain—Prednisone—ulcerative colitis	3.09e-05	0.000347	CcSEcCtD
Etoricoxib—Nausea—Prednisolone—ulcerative colitis	3.09e-05	0.000347	CcSEcCtD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ulcerative colitis	3.09e-05	0.00065	CbGpPWpGaD
Etoricoxib—MAPK14—MyD88 cascade initiated on plasma membrane—IL6—ulcerative colitis	3.07e-05	0.000647	CbGpPWpGaD
Etoricoxib—Pruritus—Betamethasone—ulcerative colitis	3.07e-05	0.000345	CcSEcCtD
Etoricoxib—Pruritus—Dexamethasone—ulcerative colitis	3.07e-05	0.000345	CcSEcCtD
Etoricoxib—MAPK14—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—ulcerative colitis	3.05e-05	0.000641	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—IL1B—ulcerative colitis	3.04e-05	0.00064	CbGpPWpGaD
Etoricoxib—PTGS2—Selenium Micronutrient Network—NFKB1—ulcerative colitis	3.04e-05	0.00064	CbGpPWpGaD
Etoricoxib—Vomiting—Triamcinolone—ulcerative colitis	3.04e-05	0.000342	CcSEcCtD
Etoricoxib—Vomiting—Methylprednisolone—ulcerative colitis	3.04e-05	0.000341	CcSEcCtD
Etoricoxib—CYP1A2—Biological oxidations—PTGS1—ulcerative colitis	3.03e-05	0.000637	CbGpPWpGaD
Etoricoxib—Nausea—Hydrocortisone—ulcerative colitis	3.02e-05	0.000339	CcSEcCtD
Etoricoxib—Rash—Triamcinolone—ulcerative colitis	3.02e-05	0.000339	CcSEcCtD
Etoricoxib—Dermatitis—Triamcinolone—ulcerative colitis	3.01e-05	0.000338	CcSEcCtD
Etoricoxib—Rash—Methylprednisolone—ulcerative colitis	3.01e-05	0.000338	CcSEcCtD
Etoricoxib—Dermatitis—Methylprednisolone—ulcerative colitis	3.01e-05	0.000338	CcSEcCtD
Etoricoxib—Urticaria—Prednisone—ulcerative colitis	3e-05	0.000337	CcSEcCtD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—ALB—ulcerative colitis	3e-05	0.000632	CbGpPWpGaD
Etoricoxib—Headache—Triamcinolone—ulcerative colitis	3e-05	0.000337	CcSEcCtD
Etoricoxib—Headache—Methylprednisolone—ulcerative colitis	2.99e-05	0.000336	CcSEcCtD
Etoricoxib—MAPK14—MyD88 dependent cascade initiated on endosome—IL6—ulcerative colitis	2.99e-05	0.000629	CbGpPWpGaD
Etoricoxib—Abdominal pain—Prednisone—ulcerative colitis	2.99e-05	0.000336	CcSEcCtD
Etoricoxib—Diarrhoea—Dexamethasone—ulcerative colitis	2.97e-05	0.000334	CcSEcCtD
Etoricoxib—Diarrhoea—Betamethasone—ulcerative colitis	2.97e-05	0.000334	CcSEcCtD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—JAK2—ulcerative colitis	2.95e-05	0.000621	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	2.95e-05	0.000621	CbGpPWpGaD
Etoricoxib—CYP2E1—liver—ulcerative colitis	2.94e-05	0.0221	CbGeAlD
Etoricoxib—MAPK14—TCR Signaling Pathway—IL6—ulcerative colitis	2.94e-05	0.000618	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—CXCL8—ulcerative colitis	2.92e-05	0.000615	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	2.89e-05	0.000609	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—IFNG—ulcerative colitis	2.89e-05	0.000608	CbGpPWpGaD
Etoricoxib—MAPK14—BDNF signaling pathway—STAT3—ulcerative colitis	2.89e-05	0.000607	CbGpPWpGaD
Etoricoxib—MAPK14—Toll Like Receptor 9 (TLR9) Cascade—IL6—ulcerative colitis	2.89e-05	0.000607	CbGpPWpGaD
Etoricoxib—Dizziness—Dexamethasone—ulcerative colitis	2.87e-05	0.000322	CcSEcCtD
Etoricoxib—Dizziness—Betamethasone—ulcerative colitis	2.87e-05	0.000322	CcSEcCtD
Etoricoxib—MAPK14—TGF-beta Signaling Pathway—TGFB1—ulcerative colitis	2.87e-05	0.000603	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CALM3—ulcerative colitis	2.86e-05	0.000602	CbGpPWpGaD
Etoricoxib—Nausea—Triamcinolone—ulcerative colitis	2.84e-05	0.000319	CcSEcCtD
Etoricoxib—MAPK14—MAPK Signaling Pathway—NFKB1—ulcerative colitis	2.84e-05	0.000597	CbGpPWpGaD
Etoricoxib—Nausea—Methylprednisolone—ulcerative colitis	2.84e-05	0.000318	CcSEcCtD
Etoricoxib—MAPK14—MyD88:Mal cascade initiated on plasma membrane—IL6—ulcerative colitis	2.84e-05	0.000597	CbGpPWpGaD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—TP53—ulcerative colitis	2.84e-05	0.000596	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—RIPK2—ulcerative colitis	2.82e-05	0.000593	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—JAK2—ulcerative colitis	2.79e-05	0.000587	CbGpPWpGaD
Etoricoxib—Hypersensitivity—Prednisone—ulcerative colitis	2.79e-05	0.000313	CcSEcCtD
Etoricoxib—Vomiting—Betamethasone—ulcerative colitis	2.76e-05	0.00031	CcSEcCtD
Etoricoxib—Vomiting—Dexamethasone—ulcerative colitis	2.76e-05	0.00031	CcSEcCtD
Etoricoxib—Rash—Betamethasone—ulcerative colitis	2.74e-05	0.000307	CcSEcCtD
Etoricoxib—Rash—Dexamethasone—ulcerative colitis	2.74e-05	0.000307	CcSEcCtD
Etoricoxib—Dermatitis—Dexamethasone—ulcerative colitis	2.74e-05	0.000307	CcSEcCtD
Etoricoxib—Dermatitis—Betamethasone—ulcerative colitis	2.74e-05	0.000307	CcSEcCtD
Etoricoxib—MAPK14—MyD88-independent cascade—IL6—ulcerative colitis	2.72e-05	0.000572	CbGpPWpGaD
Etoricoxib—Headache—Dexamethasone—ulcerative colitis	2.72e-05	0.000305	CcSEcCtD
Etoricoxib—Headache—Betamethasone—ulcerative colitis	2.72e-05	0.000305	CcSEcCtD
Etoricoxib—Asthenia—Prednisone—ulcerative colitis	2.71e-05	0.000305	CcSEcCtD
Etoricoxib—PTGS2—liver—ulcerative colitis	2.71e-05	0.0203	CbGeAlD
Etoricoxib—PTGS2—Spinal Cord Injury—CXCL8—ulcerative colitis	2.69e-05	0.000566	CbGpPWpGaD
Etoricoxib—Pruritus—Prednisone—ulcerative colitis	2.68e-05	0.0003	CcSEcCtD
Etoricoxib—MAPK14—Toll-like Receptor Signaling Pathway—IL6—ulcerative colitis	2.66e-05	0.000559	CbGpPWpGaD
Etoricoxib—MAPK14—EGF/EGFR Signaling Pathway—STAT3—ulcerative colitis	2.63e-05	0.000553	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CHP1—ulcerative colitis	2.62e-05	0.000551	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—NFKB1—ulcerative colitis	2.62e-05	0.00055	CbGpPWpGaD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—IL6—ulcerative colitis	2.6e-05	0.000546	CbGpPWpGaD
Etoricoxib—Diarrhoea—Prednisone—ulcerative colitis	2.59e-05	0.000291	CcSEcCtD
Etoricoxib—PTGS2—Spinal Cord Injury—IL1B—ulcerative colitis	2.58e-05	0.000543	CbGpPWpGaD
Etoricoxib—Nausea—Dexamethasone—ulcerative colitis	2.58e-05	0.00029	CcSEcCtD
Etoricoxib—Nausea—Betamethasone—ulcerative colitis	2.58e-05	0.00029	CcSEcCtD
Etoricoxib—MAPK14—Regulation of toll-like receptor signaling pathway—TNF—ulcerative colitis	2.57e-05	0.000541	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—IL2—ulcerative colitis	2.57e-05	0.00054	CbGpPWpGaD
Etoricoxib—MAPK14—Oxidative Stress Induced Senescence—TP53—ulcerative colitis	2.57e-05	0.00054	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	2.56e-05	0.000539	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—NOD2—ulcerative colitis	2.56e-05	0.000538	CbGpPWpGaD
Etoricoxib—MAPK14—VEGFA-VEGFR2 Pathway—IL6—ulcerative colitis	2.56e-05	0.000538	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CD14—ulcerative colitis	2.54e-05	0.000535	CbGpPWpGaD
Etoricoxib—Dizziness—Prednisone—ulcerative colitis	2.5e-05	0.000281	CcSEcCtD
Etoricoxib—MAPK14—Activated TLR4 signalling—IL6—ulcerative colitis	2.45e-05	0.000515	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—IL2—ulcerative colitis	2.43e-05	0.000512	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—MMP9—ulcerative colitis	2.43e-05	0.000512	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by VEGF—IL6—ulcerative colitis	2.41e-05	0.000508	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	2.41e-05	0.000507	CbGpPWpGaD
Etoricoxib—Vomiting—Prednisone—ulcerative colitis	2.4e-05	0.00027	CcSEcCtD
Etoricoxib—Rash—Prednisone—ulcerative colitis	2.38e-05	0.000268	CcSEcCtD
Etoricoxib—Dermatitis—Prednisone—ulcerative colitis	2.38e-05	0.000267	CcSEcCtD
Etoricoxib—Headache—Prednisone—ulcerative colitis	2.37e-05	0.000266	CcSEcCtD
Etoricoxib—CYP3A4—liver—ulcerative colitis	2.37e-05	0.0178	CbGeAlD
Etoricoxib—PTGS2—Selenium Micronutrient Network—TNF—ulcerative colitis	2.37e-05	0.000498	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—TGFB1—ulcerative colitis	2.37e-05	0.000497	CbGpPWpGaD
Etoricoxib—MAPK14—TGF-beta Signaling Pathway—TP53—ulcerative colitis	2.36e-05	0.000497	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—ITGAL—ulcerative colitis	2.35e-05	0.000495	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—STAT3—ulcerative colitis	2.35e-05	0.000495	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—RELA—ulcerative colitis	2.35e-05	0.000493	CbGpPWpGaD
Etoricoxib—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	2.34e-05	0.000492	CbGpPWpGaD
Etoricoxib—CYP2D6—liver—ulcerative colitis	2.33e-05	0.0175	CbGeAlD
Etoricoxib—MAPK14—Toll Like Receptor 4 (TLR4) Cascade—IL6—ulcerative colitis	2.3e-05	0.000484	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—SEL1L—ulcerative colitis	2.28e-05	0.00048	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—JAK2—ulcerative colitis	2.27e-05	0.000478	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	2.25e-05	0.000473	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	2.25e-05	0.000473	CbGpPWpGaD
Etoricoxib—Nausea—Prednisone—ulcerative colitis	2.25e-05	0.000252	CcSEcCtD
Etoricoxib—MAPK14—Immune System—IRF5—ulcerative colitis	2.24e-05	0.00047	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—CXCL8—ulcerative colitis	2.21e-05	0.000465	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—TNF—ulcerative colitis	2.21e-05	0.000465	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—RELA—ulcerative colitis	2.2e-05	0.000463	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—CHP1—ulcerative colitis	2.19e-05	0.000461	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—STAT3—ulcerative colitis	2.17e-05	0.000456	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CCR6—ulcerative colitis	2.14e-05	0.000449	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IRF8—ulcerative colitis	2.14e-05	0.000449	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	2.13e-05	0.000449	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—SEL1L—ulcerative colitis	2.08e-05	0.000438	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—ADCY5—ulcerative colitis	2.08e-05	0.000437	CbGpPWpGaD
Etoricoxib—MAPK14—Regulation of toll-like receptor signaling pathway—IL6—ulcerative colitis	2.07e-05	0.000436	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—HNF4A—ulcerative colitis	2.07e-05	0.000435	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—CHP1—ulcerative colitis	2.06e-05	0.000434	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	2.06e-05	0.000432	CbGpPWpGaD
Etoricoxib—MAPK14—Toll-Like Receptors Cascades—IL6—ulcerative colitis	2.05e-05	0.000431	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—MMP1—ulcerative colitis	2.04e-05	0.00043	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—FCGR2A—ulcerative colitis	2.04e-05	0.000429	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—MAML2—ulcerative colitis	2.01e-05	0.000424	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—TGFB1—ulcerative colitis	2e-05	0.000422	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	1.99e-05	0.000419	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—NFKB1—ulcerative colitis	1.98e-05	0.000416	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—PTPN2—ulcerative colitis	1.95e-05	0.000411	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—TP53—ulcerative colitis	1.95e-05	0.00041	CbGpPWpGaD
Etoricoxib—PTGS2—Selenium Micronutrient Network—IL6—ulcerative colitis	1.91e-05	0.000402	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	1.9e-05	0.000399	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—DLD—ulcerative colitis	1.89e-05	0.000398	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CXCR1—ulcerative colitis	1.88e-05	0.000395	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—TNF—ulcerative colitis	1.87e-05	0.000394	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—LTF—ulcerative colitis	1.87e-05	0.000392	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—NFKB1—ulcerative colitis	1.86e-05	0.00039	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CRP—ulcerative colitis	1.82e-05	0.000382	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—TP53—ulcerative colitis	1.79e-05	0.000378	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—DLD—ulcerative colitis	1.78e-05	0.000375	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—STAT3—ulcerative colitis	1.78e-05	0.000374	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	1.76e-05	0.00037	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—PPARG—ulcerative colitis	1.75e-05	0.000369	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—TLR4—ulcerative colitis	1.74e-05	0.000367	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CALM3—ulcerative colitis	1.67e-05	0.000351	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—STAT3—ulcerative colitis	1.67e-05	0.000351	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—TP53—ulcerative colitis	1.65e-05	0.000347	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CCL20—ulcerative colitis	1.65e-05	0.000347	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—RIPK2—ulcerative colitis	1.64e-05	0.000346	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—IL6—ulcerative colitis	1.64e-05	0.000346	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	1.64e-05	0.000344	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CTLA4—ulcerative colitis	1.62e-05	0.000341	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CHP1—ulcerative colitis	1.59e-05	0.000335	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—GNA12—ulcerative colitis	1.55e-05	0.000326	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—ALB—ulcerative colitis	1.55e-05	0.000326	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD79A—ulcerative colitis	1.55e-05	0.000325	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—IL6—ulcerative colitis	1.51e-05	0.000318	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—IL6—ulcerative colitis	1.51e-05	0.000318	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.49e-05	0.000314	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—NOD2—ulcerative colitis	1.49e-05	0.000313	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD14—ulcerative colitis	1.48e-05	0.000312	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CXCR2—ulcerative colitis	1.47e-05	0.000309	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—JAK2—ulcerative colitis	1.47e-05	0.000309	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CHP1—ulcerative colitis	1.47e-05	0.000308	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CHP1—ulcerative colitis	1.45e-05	0.000305	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—JAK2—ulcerative colitis	1.44e-05	0.000303	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—VCAM1—ulcerative colitis	1.43e-05	0.000301	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HLA-DQA1—ulcerative colitis	1.43e-05	0.0003	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—RELA—ulcerative colitis	1.42e-05	0.000299	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CCR6—ulcerative colitis	1.38e-05	0.000291	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—DLD—ulcerative colitis	1.37e-05	0.000289	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	1.36e-05	0.000287	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.36e-05	0.000286	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—TP53—ulcerative colitis	1.36e-05	0.000285	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—SLC11A1—ulcerative colitis	1.33e-05	0.00028	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MAML2—ulcerative colitis	1.31e-05	0.000275	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—JAK2—ulcerative colitis	1.3e-05	0.000272	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—VDR—ulcerative colitis	1.29e-05	0.000271	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	1.27e-05	0.000268	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—DLD—ulcerative colitis	1.26e-05	0.000266	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—IL2—ulcerative colitis	1.26e-05	0.000264	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—RELA—ulcerative colitis	1.25e-05	0.000264	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—DLD—ulcerative colitis	1.25e-05	0.000264	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—IL6—ulcerative colitis	1.24e-05	0.000261	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CHP1—ulcerative colitis	1.24e-05	0.000261	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CD4—ulcerative colitis	1.23e-05	0.000258	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PTGER4—ulcerative colitis	1.22e-05	0.000256	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—MMP9—ulcerative colitis	1.21e-05	0.000255	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—ADCY5—ulcerative colitis	1.21e-05	0.000255	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—NFKB1—ulcerative colitis	1.2e-05	0.000252	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—MAML2—ulcerative colitis	1.19e-05	0.000251	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—IL6—ulcerative colitis	1.16e-05	0.000245	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.16e-05	0.000245	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	1.12e-05	0.000236	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—GHRL—ulcerative colitis	1.11e-05	0.000234	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CALM3—ulcerative colitis	1.08e-05	0.000227	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—STAT3—ulcerative colitis	1.08e-05	0.000226	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—DLD—ulcerative colitis	1.07e-05	0.000225	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—RIPK2—ulcerative colitis	1.06e-05	0.000223	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CRP—ulcerative colitis	1.06e-05	0.000223	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—NFKB1—ulcerative colitis	1.06e-05	0.000223	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—TLR4—ulcerative colitis	1.02e-05	0.000214	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HLA-DRB1—ulcerative colitis	1.01e-05	0.000213	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1e-05	0.000211	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—TGFB1—ulcerative colitis	9.98e-06	0.00021	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CALM3—ulcerative colitis	9.84e-06	0.000207	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—TGFB1—ulcerative colitis	9.79e-06	0.000206	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—ICAM1—ulcerative colitis	9.73e-06	0.000205	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CHP1—ulcerative colitis	9.58e-06	0.000201	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—TNF—ulcerative colitis	9.32e-06	0.000196	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—ADRB2—ulcerative colitis	9.22e-06	0.000194	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PTGS1—ulcerative colitis	9.15e-06	0.000193	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	9e-06	0.000189	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—PPARG—ulcerative colitis	8.98e-06	0.000189	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PTGS1—ulcerative colitis	8.62e-06	0.000181	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CDH1—ulcerative colitis	8.61e-06	0.000181	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—DLD—ulcerative colitis	8.27e-06	0.000174	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—CALM3—ulcerative colitis	8.24e-06	0.000173	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—TP53—ulcerative colitis	8.06e-06	0.00017	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—ADCY5—ulcerative colitis	7.82e-06	0.000165	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—CALM3—ulcerative colitis	7.76e-06	0.000163	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—JAK2—ulcerative colitis	7.55e-06	0.000159	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—IL6—ulcerative colitis	7.52e-06	0.000158	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IFNG—ulcerative colitis	7.41e-06	0.000156	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—RELA—ulcerative colitis	7.31e-06	0.000154	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	7.27e-06	0.000153	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD4—ulcerative colitis	7.15e-06	0.00015	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—ADCY5—ulcerative colitis	7.14e-06	0.00015	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PTGS1—ulcerative colitis	6.65e-06	0.00014	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—IL6—ulcerative colitis	6.64e-06	0.00014	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	6.63e-06	0.000139	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL1B—ulcerative colitis	6.61e-06	0.000139	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL2—ulcerative colitis	6.58e-06	0.000138	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	6.54e-06	0.000138	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—ABCB1—ulcerative colitis	6.41e-06	0.000135	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—NFKB1—ulcerative colitis	6.16e-06	0.00013	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PTGS1—ulcerative colitis	6.11e-06	0.000129	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PTGS1—ulcerative colitis	6.06e-06	0.000127	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—ABCB1—ulcerative colitis	6.03e-06	0.000127	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CALM3—ulcerative colitis	5.98e-06	0.000126	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—ADCY5—ulcerative colitis	5.98e-06	0.000126	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	5.96e-06	0.000125	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	5.72e-06	0.00012	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	5.67e-06	0.000119	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—ADCY5—ulcerative colitis	5.63e-06	0.000118	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—STAT3—ulcerative colitis	5.54e-06	0.000116	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CALM3—ulcerative colitis	5.5e-06	0.000116	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CALM3—ulcerative colitis	5.46e-06	0.000115	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	5.22e-06	0.00011	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PTGS1—ulcerative colitis	5.18e-06	0.000109	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	5.09e-06	0.000107	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—JAK2—ulcerative colitis	4.88e-06	0.000103	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—RELA—ulcerative colitis	4.72e-06	9.94e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CALM3—ulcerative colitis	4.66e-06	9.81e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ABCB1—ulcerative colitis	4.65e-06	9.79e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PPARG—ulcerative colitis	4.46e-06	9.38e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	4.46e-06	9.37e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CXCL8—ulcerative colitis	4.45e-06	9.36e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—JAK2—ulcerative colitis	4.45e-06	9.36e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ADCY5—ulcerative colitis	4.34e-06	9.13e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ABCB1—ulcerative colitis	4.28e-06	9e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL2—ulcerative colitis	4.25e-06	8.95e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ABCB1—ulcerative colitis	4.24e-06	8.93e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CD4—ulcerative colitis	4.22e-06	8.87e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PPARG—ulcerative colitis	4.2e-06	8.83e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MMP9—ulcerative colitis	4.03e-06	8.47e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—ALB—ulcerative colitis	4.01e-06	8.43e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PTGS1—ulcerative colitis	4e-06	8.41e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ADCY5—ulcerative colitis	3.99e-06	8.4e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—NFKB1—ulcerative colitis	3.98e-06	8.38e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ADCY5—ulcerative colitis	3.96e-06	8.33e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL6—ulcerative colitis	3.87e-06	8.14e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—ALB—ulcerative colitis	3.77e-06	7.94e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ABCB1—ulcerative colitis	3.63e-06	7.63e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CALM3—ulcerative colitis	3.6e-06	7.57e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—STAT3—ulcerative colitis	3.58e-06	7.53e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ADCY5—ulcerative colitis	3.38e-06	7.12e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TGFB1—ulcerative colitis	3.32e-06	6.98e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PTGS2—ulcerative colitis	3.3e-06	6.94e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—STAT3—ulcerative colitis	3.27e-06	6.87e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PPARG—ulcerative colitis	3.24e-06	6.81e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—TGFB1—ulcerative colitis	3.03e-06	6.37e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PPARG—ulcerative colitis	2.98e-06	6.26e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PPARG—ulcerative colitis	2.95e-06	6.21e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ALB—ulcerative colitis	2.91e-06	6.12e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ABCB1—ulcerative colitis	2.8e-06	5.89e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TP53—ulcerative colitis	2.73e-06	5.75e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ALB—ulcerative colitis	2.68e-06	5.63e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ALB—ulcerative colitis	2.65e-06	5.58e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ADCY5—ulcerative colitis	2.61e-06	5.49e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PTGS2—ulcerative colitis	2.55e-06	5.36e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PPARG—ulcerative colitis	2.52e-06	5.31e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL6—ulcerative colitis	2.5e-06	5.26e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PTGS2—ulcerative colitis	2.34e-06	4.93e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PTGS2—ulcerative colitis	2.32e-06	4.89e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—IL6—ulcerative colitis	2.28e-06	4.8e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ALB—ulcerative colitis	2.27e-06	4.77e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PTGS2—ulcerative colitis	1.98e-06	4.17e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PPARG—ulcerative colitis	1.95e-06	4.1e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ALB—ulcerative colitis	1.75e-06	3.68e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PTGS2—ulcerative colitis	1.53e-06	3.22e-05	CbGpPWpGaD
